Estrategia de codigestión : empleo de biosólidos industriales para potenciar la cogeneración en instalaciones depuradoras convencionales : estudio de viabilidad en un área concreta

Este trabajo fin de grado tiene como objetivos: 1. Realizar un análisis de situación de la producción de biogás en el periodo comprendido entre los años 2011 y 2014 en la EDAR Cabezo Beaza. 2. Desarrollar un estudio de viabilidad de la introducción de procesos de codigestión para potenciar la producción de biogás en la EDAR Cabezo Beaza. 3. Analizar el efecto del cosustrato FORSU o LIXIVIADO en el proceso de digestión anaerobia de forma que implique un incremento en el rendimiento de cogeneración de la planta.Escuela Técnica Superior de Ingeniería IndustrialUniversidad Politécnica de Cartagen

Movilidad del pensamiento entorno a Re-crear el concepto agua

Re-crear el concepto Agua utilizando como mediadores estéticos los tránsitos literarios y los órganos de los sentidos; para de esta forma explorar las esferas estéticas, sociales, eróticas, vital - biológicas que confluyen en el mundo de la vida1. Articulación a la línea de investigación educativa biológica y ambiental, del programa de licenciatura en biología y educación ambiental 8 2. Pregunta fundamental 8 3. Pregunta orientadora 9 4. Propósito creador 9 5. Alcances pretendidos 10 6. Motivación 10 7. Entorno al problema 12 8. Dimensiones del theoros 15 9. Método propio 24PregradoProfesional en Seguridad y Salud en el Trabaj

Study of the optimal waveforms for non-destructive spectral analysis of aqueous solutions by means of audible sound and optimization algorithms

Acoustic analysis of materials is a common non-destructive technique, but most efforts are focused on the ultrasonic range. In the audible range, such studies are generally devoted to audio engineering applications. Ultrasonic sound has evident advantages, but also severe limitations, like penetration depth and the use of coupling gels. We propose a biomimetic approach in the audible range to overcome some of these limitations. A total of 364 samples of water and fructose solutions with 28 concentrations between 0 g/L and 9 g/L have been analyzed inside an anechoic chamber using audible sound configurations. The spectral information from the scattered sound is used to identify and discriminate the concentration with the help of an improved grouping genetic algorithm that extracts a set of frequencies as a classifier. The fitness function of the optimization algorithm implements an extreme learning machine. The classifier obtained with this new technique is composed only by nine frequencies in the (3–15) kHz range. The results have been obtained over 20,000 independent random iterations, achieving an average classification accuracy of 98.65% for concentrations with a difference of ±0.01 g/L

Pseudomonas aeruginosa Community-Onset Bloodstream Infections: Characterization, Diagnostic Predictors, and Predictive Score Development—Results from the PRO-BAC Cohort

Pseudomonas aeruginosa; Infección del torrente sanguíneo; EpidemiologíaPseudomones aeruginosa; Infecció del torrent sanguini; EpidemiologiaPseudomonas aeruginosa; Bloodstream infection; EpidemiologyCommunity-onset bloodstream infections (CO-BSI) caused by gram-negative bacilli are common and associated with significant mortality; those caused by Pseudomonas aeruginosa are associated with worse prognosis and higher rates of inadequateempirical antibiotic treatment. The aims of this study were to describe the characteristics of patients with CO-BSI caused by P. aeruginosa, to identify predictors, and to develop a predictive score for P. aeruginosa CO-BSI. Materials/methods: PROBAC is a prospective cohort including patients >14 years with BSI from 26 Spanish hospitals between October 2016 and May 2017. Patients with monomicrobial P. aeruginosa CO-BSI and monomicrobial Enterobacterales CO-BSI were included. Variables of interest were collected. Independent predictors of Pseudomonas aeruginosa CO-BSI were identified by logistic regression and a prediction score was developed. Results: A total of 78patients with P. aeruginosa CO-BSI and 2572 with Enterobacterales CO-BSI were included. Patients with P. aeruginosa had a median age of 70 years (IQR 60-79), 68.8% were male, median Charlson score was 5 (IQR 3-7), and 30-daymortality was 18.5%. Multivariate analysis identified the following predictors of CO-BSI-PA [adjusted OR (95% CI)]: male gender [1.89 (1.14-3.12)], haematological malignancy [2.45 (1.20-4.99)], obstructive uropathy [2.86 (1.13-3.02)], source of infection other than urinary tract, biliary tract or intra-abdominal [6.69 (4.10-10.92)] and healthcare-associated BSI [1.85 (1.13-3.02)]. Anindex predictive of CO-BSI-PA was developed; scores ≥ 3.5 showed a negative predictive value of 89% and an area under the receiver operator curve (ROC) of 0.66. Conclusions: We did not find a good predictive score of P. aeruginosa CO-BSI due to its relatively low incidence in the overall population. Our model includes variables that are easy to collect in real clinical practice and could be useful to detect patients with very low risk of P. aeruginosa CO-BSI

PBL aplicado a los estudios de Historia del Arte. Elaboración de materiales didácticos para el Grado en Historia del Arte

El Aprendizaje Basado en Proyectos (PBL) es una metodología alternativa y/o complementaria a las nuevas enseñanzas utilizada en muchas universidades del mundo. En el proyecto se ha llevado a cabo, además de un empleo del sistema en las clases, la elaboración de materiales didácticos

Vigilancia del COVID-19 en centros de larga estancia: el efecto de la pandemia en las residencias de mayores

[ES] Este informe muestra la situación epidemiológica de la COVID-19 en los centros residenciales de mayores a lo largo del año 2021 y hasta la semana 17 del 2022. Desde su puesta en marcha en enero de 2021, esta vigilancia ha proporcionado datos semanales nacionales agregados, con información sobre la proporción de residencias afectadas por la COVID-19, la incidencia de COVID-19 y la letalidad entre una población vulnerable donde los efectos de la pandemia han sido y están siendo especialmente graves. La comparación con la incidencia y mortalidad de casos COVID-19 en población mayor no institucionalizada, nos demuestra cómo el impacto de la COVID-19 ha sido y está siendo mayor entre las personas mayores que viven en residencias de ancianos, con tasas de mortalidad superiores al resto de la población de la misma edad. [EN] This report shows the epidemiological situation of COVID-19 in the long-term care facilities (LTCF) for elderly throughout 2021 and until the 17th week of 2022. Since its start-up in January 2021, this surveillance has provided aggregated national weekly data, with information on the proportion of LTCF for elderly affected by COVID-19, the incidence of COVID-19 and fatal cases among a vulnerable population where the effects of the pandemic have been and are being especially severe. The comparison with the incidence and mortality of COVID-19 cases in non institutionalized elderly shows how the impact of COVID-19 is being greater among the elderly living in nursing homes, with more fatal cases than the rest of the population of the same age

Effectiveness of Modified Vaccinia Ankara-Bavaria Nordic Vaccination in a Population at High Risk of Mpox: A Spanish Cohort Study

Background: With over 7,500 cases notified since April 2022, Spain has experienced the highest incidence of mpox in Europe. From July 12th onwards, the Modified Vaccinia Ankara-Bavaria Nordic (MVA-BN) smallpox vaccine was offered as pre-exposure prophylaxis for individuals at high-risk of mpox, including those receiving pre-exposure prophylaxis for HIV (HIV-PrEP). Our aim was to assess the effectiveness of one dose of MVA-BN vaccine as pre-exposure against mpox virus (MPXV) infection in persons on HIV-PrEP. Methods: We conducted a national retrospective cohort study between July 12 and December 12, 2022. Individuals ≥18 years, receiving HIV-PrEP as of July 12 and with no previous MPXV infection or vaccination were eligible. Each day, we matched individuals receiving a first dose of MVA-BN vaccine and unvaccinated controls of the same age group and region. We used a Kaplan-Meier estimator and calculate risk ratios (RR) and vaccine effectiveness (VE = 1-RR). Results: We included 5,660 matched pairs, with a median follow-up of 62 days (interquartile range 24-97). Mpox cumulative incidence was 5.6 per 1,000 (25 cases) in unvaccinated and 3.5 per 1,000 (18 cases) in vaccinated. No effect was found during days 0-6 post-vaccination (VE -38.3; 95% confidence interval (95%CI): -332.7; 46.4), but VE was 65% in ≥7 days (95%CI 22.9; 88.0) and 79% in ≥14 days (95%CI 33.3; 100.0) post-vaccination. Conclusions: One dose of MVA-BN vaccine offered protection against mpox in a most-at-risk population shortly after the vaccination. Further studies need to assess the VE of a second dose and the duration of protection over time.S

A precision medicine test predicts clinical response after idarubicin and cytarabine induction therapy in AML patients

Complete remission (CR) after induction therapy is the first treatment goal in acute myeloid leukemia (AML) patients and has prognostic impact. Our purpose is to determine the correlation between the observed CR/CRi rate after idarubicin (IDA) and cytarabine (CYT) 3 + 7 induction and the leukemic chemosensitivity measured by an ex vivo test of drug activity. Bone marrow samples from adult patients with newly diagnosed AML were included in this study. Whole bone marrow samples were incubated for 48 h in well plates containing IDA, CYT, or their combination. Pharmacological response parameters were estimated using population pharmacodynamic models. Patients attaining a CR/CRi with up to two induction cycles of 3 + 7 were classified as responders and the remaining as resistant. A total of 123 patients fulfilled the inclusion criteria and were evaluable for correlation analyses. The strongest clinical predictors were the area under the curve of the concentration response curves of CYT and IDA. The overall accuracy achieved using MaxSpSe criteria to define positivity was 81%, predicting better responder (93%) than non-responder patients (60%). The ex vivo test provides better yet similar information than cytogenetics, but can be provided before treatment representing a valuable in-time addition. After validation in an external cohort, this novel ex vivo test could be useful to select AML patients for 3 + 7 regimen vs. alternative schedules

Cell Count Differentials by Cytomorphology and Next-Generation Flow Cytometry in Bone Marrow Aspirate: An Evidence-Based Approach

Despite a lack of evidence, a bone marrow aspirate differential of 500 cells is commonly used in the clinical setting. We aimed to test the performance of 200-cell counts for daily hematological workup. In total, 660 consecutive samples were analyzed recording differentials at 200 and 500 cells. Additionally, immunophenotype results and preanalytical issues were also evaluated. Clinical and statistical differences between both cutoffs and both methods were checked. An independent control group of 122 patients was included. All comparisons between both cutoffs and both methods for all relevant types of cells did not show statistically significant differences. No significant diagnostic discrepancies were demonstrated in the contingency table analysis. This is a real-life study, and some limitations may be pointed out, such as a different sample sizes according to the type of cell in the immunophenotype analysis, the lack of standardization of some preanalytical events, and the relatively small sample size of the control group. The comparisons of differentials by morphology on 200 and 500 cells, as well as by morphology (both cutoffs) and by immunophenotype, are equivalent from the clinical and statistical point of view. The preanalytical issues play a critical role in the assessment of bone marrow aspirate samples